Division of Medical Oncology
Division of Medical Oncology

The Department of Medical Oncology of SYSMH was established in 1998 and has since developed into a sizable and advanced center for cancer research and treatment. It possesses extensive clinical experience in the diagnosis and comprehensive treatment of malignancies in areas such as the head and neck, thoracic region, digestive system, hematologic system, bone and soft tissues, and genitourinary system. It has cultivated a well-structured, highly skilled, and experienced medical team. Currently, the department consists of 19 specialist physicians and 1 technician, including 3 with senior professional titles, 3 with associate senior titles, 2 attending physicians, and 10 resident physicians.
The Department of Medical Oncology is an integral part of the National Health Commission and Guangdong Provincial Key Clinical Specialty in Oncology. It serves as a postdoctoral workstation in oncology for Sun Yat-sen University, a doctoral admissions site for oncology at Sun Yat-sen University, and the designated successor unit for the Tumor Metastasis Professional Committee of the Guangdong Anti-Cancer Association.
The department operates two inpatient wards: Medical Oncology Ward I and Medical Oncology Ward II. It is further divided into two subspecialties: Gastrointestinal Tumor Chemotherapy and Thoracic Tumor Chemotherapy. The department primarily focuses on radical chemotherapy, adjuvant chemotherapy, neoadjuvant chemotherapy, palliative chemotherapy, molecular targeted therapy, hyperthermia center services, concurrent chemoradiotherapy, and tumor biotherapy. The newly established Tumor Biotherapy Division, based in Medical Oncology Ward II, conducts treatments including tumor vaccines, immune cell infusion, CAR-T therapy, and immune checkpoint inhibitor therapy. Currently, the department is overseen by Deputy Director Li Zhihua, with Hu Hai serving as the associate director.
The department has also achieved rapid development in both clinical and basic research. Over the past five years, it has secured multiple national and provincial-level research projects and published over 40 SCI-indexed papers, including in internationally renowned journals such as Cell, JAMA Network Open, Cancer Research, and Clinical Cancer Research.

More

Featured Medical Technology

The Department of Medical Oncology was established in 1998 and has since developed into a sizable, high-level center for cancer research and treatment, integrating clinical practice, medical education, and scientific research. It is a National and Guangdong Provincial Key Clinical Specialty in Oncology, a key unit in the National Program for Enhancing Capacity in Diagnosing and Treating Difficult Diseases specifically for oncology, the Chair Unit of the Tumor Metastasis Professional Committee of the Guangdong Anti-Cancer Association, and holds positions as a Standing Committee Member of the Tumor Metabolism Professional Committee of the Chinese Anti-Cancer Association and the Deputy Head Unit of its Clinical Metabolism Group. The department is committed to promoting standardized cancer diagnosis/treatment and the application of new technologies, wielding extensive academic influence both domestically and internationally.
The department currently operates two inpatient wards and comprises three subspecialties: Thoracic Oncology, Gastrointestinal Oncology, and Cancer Biotherapy. It emphasizes standardized chemotherapy and comprehensive cancer treatment, offering advanced therapies including CAR-T therapy, immune checkpoint inhibitor treatment, tumor vaccines, and immune cell infusion. The department also undertakes part of the work of the Phase I Clinical Research Center, having accumulated extensive experience in the clinical research and evaluation of anti-cancer drugs. It has served as the lead or a major participant in dozens of domestic and international clinical trials for innovative anti-tumor agents. To date, the department has garnered rich clinical experience in the diagnosis and comprehensive treatment of malignancies in areas such as thoracic, gastrointestinal, genitourinary, bone and soft tissue, head and neck cancers, and lymphomas. It has fostered a well-structured medical team with robust technical expertise and profound experience. The current staff includes 23 specialist physicians and 1 technician. Among them are 1 National Distinguished Young Scholar, 3 with senior professional titles, 2 with associate senior titles, 3 attending physicians, and 14 resident physicians.

More

Scientific Research Results

The Department of Medical Oncology, serving as a postdoctoral workstation in oncology at Sun Yat-sen University as well as a doctoral and master's student enrollment site, consistently emphasizes both scientific research and translational applications. The department has secured multiple national and provincial-level research grants, including projects under the National Key Research and Development Program, the National Natural Science Foundation of China (NSFC) Distinguished Young Scholar Program, key NSFC projects, and key projects under the NSFC-Guangdong Joint Fund.
Its major research findings have been published in numerous internationally renowned journals, such as Cell, JAMA, JAMA Network Open, Cancer Research, Clinical Cancer Research, Nature Communications, Advanced Science, and Molecular Cancer. The department has conducted in-depth research on the basic, translational, and clinical aspects of tumor metastasis and contributed to winning the Second Prize of the National Natural Science Award.

More